• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • FDA clears first magnetic, noninvasive device treatment for OCD fiercebiotech
    August 21, 2018
    The FDA granted de novo clearance to the first noninvasive device treatment for obsessive compulsive disorder, Brainsway’s transcranial magnetic stimulation system, adding a new therapy for adults alongside medication and psychotherapy.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service